http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383627-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e522ef22f01c13cd40d52aaee98332c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ded7dbc78ab2af0282b0aeec2fc740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4df528a427f4bc7e35e5ccd29156f460
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c2a00e8988fc267090df663edd1646f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5053f82a7cd17c60822674b657cfb89e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
filingDate 2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2aa26e2d05a312c286975d8bfdf77363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_673a05a68667d5ba1737ddc27275c1bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13cf6b1712c20b4e936429bd3529825f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_650f0be5aed1fb109184234d3bec7635
publicationDate 2013-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8383627-B2
titleOfInvention Crystalline polymorph of doxazosin mesylate (form IV) and process for preparation thereof
abstract Crystalline Form IV of doxazosin mesylate, a process for its preparation and uses thereof.
priorityDate 2007-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0849264-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002065287-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6500830-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0848001-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2224884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2225022-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0849266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2224916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9935143-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0056731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009081087-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453343347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223738012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224475979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224475980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53695730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6604102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128339009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID324172726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447952532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226473395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129185848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID237896981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91386818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420631

Total number of triples: 57.